U.S., July 19 -- ClinicalTrials.gov registry received information related to the study (NCT07073170) titled 'A Study of LY3549492 in Chinese Participants With Type 2 Diabetes Mellitus' on July 10.
Brief Summary: The main purpose of this study is to investigate LY3549492 in Chinese participants with type 2 diabetes. Participation in the study will last about 18 weeks.
Study Start Date: Aug., 2025
Study Type: INTERVENTIONAL
Condition:
Type 2 Diabetes
Intervention:
DRUG: LY3549492
Administered orally
DRUG: Placebo
Administered orally
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Eli Lilly and Company
Published by HT Digital Content Services with permission from Health Daily Digest....